...
首页> 外文期刊>Clinical Orthopaedics and Related Research >Does fresh osteochondral allograft transplantation of talar osteochondral defects improve function?
【24h】

Does fresh osteochondral allograft transplantation of talar osteochondral defects improve function?

机译:距骨骨软骨缺损的新鲜骨软骨同种异体移植能否改善功能?

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Fresh osteochondral allograft transplantation can be used to replace talar osteochondral defects (OCDs) with single bulk osteochondral graft. While limited studies report improvement of function, improvement in quality of life and radiographic durability is unknown. QUESTIONS/PURPOSE: We therefore determined if this technique improved function, increased quality of life, and provided durable graft stability radiographically and by MRI. PATIENTS AND METHODS: We prospectively followed 19 patients (19 OCDs). We excluded seven patients (four with insufficient followup, two who were lost to followup, and one with graft failure), leaving 12 patients with a minimum followup of 2 years (average, 3.3 years; range, 2.0-4.6 years). Functional and quality of life outcomes were quantified using the American Orthopaedic Foot and Ankle Society (AOFAS) score and the SF-12 Health Survey. Graft incorporation and stability were assessed through radiographs and MRI. RESULTS: Mean total AOFAS scores (61+/-9 to 79+/-6), pain subscores (17+/-8 versus 26+/-5), and function subscores (34+/-3 versus 42+/-4) improved from preoperatively to last followup. We observed no improvements of the physical and mental health components of the SF-12 Health Survey from preoperatively to last followup. At last followup, three of the 12 grafts had radiolucencies, four had edema, one failed to incorporate, and none had subsidence. One of the 19 patients in the overall series underwent graft revision. CONCLUSIONS: Patients with talar OCDs can expect functional improvement after this technique. The majority will have stable grafts at least short term. Larger studies with longer followup are needed to determine if this procedure substantially improves quality of life, if graft radiolucencies and edema have any long-term implications, and whether the grafts are durable. LEVEL OF EVIDENCE: Level IV, therapeutic study. See Guidelines for Authors for a complete description of levels of evidence.
机译:背景:新鲜的骨软骨同种异体移植可以用来代替单个大块骨软骨移植替代距骨骨软骨缺损(OCD)。尽管有限的研究报告了功能的改善,但生活质量和射线照相耐久性的改善尚不清楚。问题/目的:因此,我们确定了这项技术是否可以通过射线照相和MRI改善功能,提高生活质量并提供持久的移植物稳定性。患者与方法:我们前瞻性随访了19例患者(19例OCD)。我们排除了7例患者(4例随访不足,2例失访,1例移植失败),其余12例患者的随访时间最少为2年(平均3.3年;范围2.0-4.6年)。使用美国矫形足踝学会(AOFAS)评分和SF-12健康调查对功能和生活质量进行量化。通过X光片和MRI评估移植物的结合和稳定性。结果:平均AOFAS总分(61 +/- 9至79 +/- 6),疼痛分(17 +/- 8对26 +/- 5)和功能分(34 +/- 3对42 +/-) 4)从术前到最后一次随访均得到改善。从术前到最后随访,我们没有观察到SF-12健康调查的身体和精神健康组成部分得到改善。在最后一次随访中,12例移植物中有3例具有放射线透明性,4例有水肿,1例未能合并,并且没有下陷。整个系列的19例患者中的1例接受了移植物翻修。结论:距骨强迫症患者可以期待这项技术后的功能改善。大多数将至少短期内拥有稳定的移植物。需要进行较大规模的随访研究,以确定该程序是否能够显着改善生活质量,移植物的放射线敏感性和水肿是否具有长期影响以及移植物是否耐用。证据级别:IV级,治疗研究。有关证据水平的完整说明,请参见《作者指南》。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号